Mitochondrial Dysfunction as a Context‐Dependent Driver and Amplifier of the SASP : Targeting the mtDNA – cGAS – STING Axis for Next‐Generation Senotherapeutics
Journal of Cellular and Molecular Medicine · 2026-11 · 30 (21)
DOI: 10.1111/jcmm.71419 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 05.11.2026. Verfasst von Hamza Kamaran Hama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Special Education, Sharazur Educational College, University of Halabja, Halabja, Iraq. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondria, Senescence-Associated Secretory Phenotype, Nucleotidyltransferases. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cellular senescence combines stable cell‐cycle arrest with mitochondrial and innate immune remodelling that shapes the senescence‐associated secretory phenotype (SASP). This narrative review evaluates mitochondrial dysfunction as a context‐dependent initiator or amplifier of senescence and examines mitochondrial DNA (mtDNA) sensing through cGAS–STING as a driver of SASP regulation. We distinguish mitochondrial damage, cytosolic mtDNA exposure, pathway activation, SASP transcription, secretion, paracrine activity and tissue outcomes as separate levels of evidence. The strongest mechanistic studies link BAX/BAK‐mediated minority mitochondrial outer‐membrane permeabilization, VDAC1 oligomerization, defective mitophagy or abnormal mtDNA composition to cytosolic mtDNA, cGAS–STING activation and SASP modulation through genetic or pharmacological perturbation. However, pathway architecture varies across cell types, tissues and senescence triggers, and nuclear DNA, micronuclei, retroelements and mitochondrial RNA can activate overlapping inflammatory programmes. Preclinical evidence therefore supports STING inhibition primarily as a senomorphic, anti‐inflammatory and tissue‐protective strategy rather than a senolytic intervention. Mitophagy enhancement, inhibition of mtDNA release, targeted protein degradation and precision delivery offer complementary approaches, but human efficacy remains unestablished. Clinical translation will require standardized biomarkers, biologically informed patient selection, pharmacodynamic confirmation, tissue‐restricted or reversible modulation and prospective assessment of antiviral, antitumour and long‐term safety. Overall, the mitochondrial dysfunction–mtDNA–cGAS–STING axis is a mechanistically credible but context‐dependent therapeutic framework whose clinical value will depend on validated pathway engagement and appropriately timed clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Special Education, Sharazur Educational College, University of Halabja, Halabja, Iraq.
- Department of Clinical Biochemistry, College of Science, University of Halabja, Halabja, Iraq.
- Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, Canada.
- Department of Food Science and Nutrition, Faculty of Agriculture and Food, Ibb University, Ibb City, Yemen.
ORCID-Profile: Hamza Kamaran Hama, Mohammed Ali Hama, Musa M Zorab, Amirreza Gholami, Ammar Mohammed Al-Farga
Zitieren
APA
Hama, H. K., Hama, M. A., Zorab, M. M., Gholami, A., & Al-Farga, A. M. (2026). Mitochondrial Dysfunction as a Context‐Dependent Driver and Amplifier of the SASP : Targeting the mtDNA – cGAS – STING Axis for Next‐Generation Senotherapeutics. Journal of Cellular and Molecular Medicine, 30(21). https://doi.org/10.1111/jcmm.71419
Vancouver
Hama HK, Hama MA, Zorab MM, Gholami A, Al-Farga AM. Mitochondrial Dysfunction as a Context‐Dependent Driver and Amplifier of the SASP : Targeting the mtDNA – cGAS – STING Axis for Next‐Generation Senotherapeutics. Journal of Cellular and Molecular Medicine. 2026;30(21). doi:10.1111/jcmm.71419
BibTeX
@article{Hama2026,
author = {Hama, Hamza Kamaran and Hama, Mohammed Ali and Zorab, Musa M and Gholami, Amirreza and Al-Farga, Ammar Mohammed},
title = {Mitochondrial Dysfunction as a Context‐Dependent Driver and Amplifier of the SASP : Targeting the mtDNA – cGAS – STING Axis for Next‐Generation Senotherapeutics},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {21},
doi = {10.1111/jcmm.71419}
}
EUVIMED